View in EDS HTML Full Text PDF Full Text

Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.

Saved in:
Bibliographic Details
Title: Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer's disease: a PET substudy interim analysis.
Authors: Klein, Gregory1 (AUTHOR) gregory.klein@roche.com, Delmar, Paul2 (AUTHOR), Voyle, Nicola3 (AUTHOR), Rehal, Sunita3 (AUTHOR), Hofmann, Carsten1 (AUTHOR), Abi-Saab, Danielle2 (AUTHOR), Andjelkovic, Mirjana2 (AUTHOR), Ristic, Smiljana2 (AUTHOR), Wang, Guoqiao4 (AUTHOR), Bateman, Randall4 (AUTHOR), Kerchner, Geoffrey A.2 (AUTHOR), Baudler, Monika2 (AUTHOR), Fontoura, Paulo2 (AUTHOR), Doody, Rachelle2,5 (AUTHOR)
Source: Alzheimer's Research & Therapy. 12/12/2019, Vol. 11 Issue 1, p1-12. 12p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:17589193
DOI:10.1186/s13195-019-0559-z